Literature DB >> 6566577

Isolation of tissue kallikrein in rat spleen by monoclonal antibody-affinity chromatography.

J Chao, L Chao, H S Margolius.   

Abstract

Rat spleen kallikrein was identified and purified by DEAE-cellulose and monoclonal antibody-affinity chromatography. The purified enzyme has Tos-Arg-OMe esterase activity and kinin-releasing activity from a purified low-molecular-weight kininogen substrate. In the direct radioimmunoassay for tissue kallikrein, the splenic enzyme displays parallelism with standard curves of rat urinary kallikrein. The pH profiles of the Tos-Arg-OMe esterase activities of spleen and urinary kallikrein were identical with optima at 9.0. Rat spleen kallikrein was inhibited strongly by aprotinin and affinity-purified kallikrein antibody and weakly by soybean trypsin inhibitor. The IC50 values were similar to those observed against rat urinary kallikrein. Neither the urinary nor the splenic enzyme was inhibited by lima bean trypsin inhibitor or preimmune serum immunoglobulins. Spleen kallikrein was labeled with [14C]diisopropylphosphorofluoridate and visualized by fluorography on a sodium dodecyl sulfate-polyacrylamide gel. The electrophoretic mobility of the splenic enzyme was indistinguishable from that of urinary kallikrein A with an estimated Mr of approx. 38 000. With Western blot analyses using a rabbit anti-kallikrein antibody followed by 125I-labeled protein A binding, the spleen and urinary kallikreins were again visualized at identical positions by autoradiography. The data show that there is a rat splenic tissue kallikrein which is indistinguishable from a renal kallikrein with respect to physicochemical properties, immunological character and susceptibility to inhibitors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6566577     DOI: 10.1016/0304-4165(84)90073-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice.

Authors:  W Xiong; J Wang; L Chao; J Chao
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast.

Authors:  J Wang; J Chao; L Chao
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

3.  Immunolocalization of renal kallikrein-like substance in rat urinary bladder.

Authors:  C Orfila; G Bompart; J C Lepert; J M Suc; J P Girolami
Journal:  Histochem J       Date:  1993-09

Review 4.  Molecular biology of tissue kallikrein.

Authors:  R J MacDonald; H S Margolius; E G Erdös
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

5.  Differential interactions of human kallikrein-binding protein and alpha 1-antitrypsin with human tissue kallikrein.

Authors:  L M Chen; L Chao; R K Mayfield; J Chao
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

6.  Specific identification of tissue kallikrein in exocrine tissues and in cell-free translation products with monoclonal antibodies.

Authors:  C M Woodley; J Chao; H S Margolius; L Chao
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

7.  Identification and characterization of a tissue kallikrein in rat skeletal muscles.

Authors:  N Shimojo; J Chao; L Chao; H S Margolius; R K Mayfield
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

8.  Identification, purification, and localization of tissue kallikrein in rat heart.

Authors:  W Xiong; L M Chen; C Woodley-Miller; J A Simson; J Chao
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

Review 9.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Cloning and expression of human salivary-gland kallikrein in Escherichia coli.

Authors:  A Angermann; C Bergmann; H Appelhans
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.